Neovasc (NVCN) Reports Q1 Loss of $0.10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Neovasc Reports Results for the First Quarter of 2015
May 12, 2015 7:00 AM EDT-- Raised aggregate gross proceeds of approximately US$74,883,850 ---- The New England Journal of Medicine publishes positive results from clinical study of Reducer ---- Company launches Reducer in select European countries --
NASDAQ: NVCNTSX: NVC
VANCOUVER, May 12, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the quarter ended March 31, 2015. All results are reported in Canadian dollars unless otherwise stated.
"Our top priority in... More
